🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07355751
Starting soon Not applicable

The Effect of Acupuncture Treatment on Cognitive Functions and Brain Networks for Long COVID

NCT07355751 · tracked via the Priya Life Science China tracker
Sponsor
Tingting Luo
Phase
Not applicable
Started
2026-05
Last updated
2026-01-21

Condition(s) studied

Long Covid

Investigational drug(s) / intervention(s)

AcupunctureSham acupuncture

Acupuncture: Two sets of acupoints will be alternatively acupunctured. The first set of acupuncture points incudes Baihui (GV20), Shenting (GV24), bilateral Neiguan (PC6), Qihai (CV6), Guanyuan (CV4), bilateral Zusanli (ST36), bilateral Sanyinjiao (SP6). The second set of acupoints consist of Sishenchong (EX-HN1), bilateral Ganshu (BL18), bilateral Pishu (BL20), bilaetral Shenshu (BL23). The treatment consists of 24 sessions of 30 minutes, given within eight weeks (three sessions per week).A set of acupoints will be acupunctured each treatment session.

Sham acupuncture: Nonpenetrating acupuncture on non-acupoints will be performed using Park sham acupuncture device (0.25 mm in diameter and 40 mm in length, Hwatuo, Suzhou, China) for participants. Two sets of non-acupoints will be alternatively acupunctured. The first set of sham acupoints includes bilateral non-acupoint 1, non-acupoint 2, non-acupoint 3, bilateral non-acupoint 4, bilateral non-acupoint 5. The second set consists of bilateral non-acupoint 6, bilateral non-acupoint 7, bilateral non-acupoint 8. The treatment consists of 24 sessions of 30 minutes, given within eight weeks (three sessions per week). A set of non-acupoints will be acupunctured each treatment session.

Study summary

Background of study:

Long COVID(LC) is a prevalent sequalae of SARS-CoV-2 infection and can affect multiple organ systems. Cognitive dysfunction is one of the most common symptoms in LC with 22% prevalence. It can persist for years and significantly reduce patients' quality of life. Brain network is the neural basis underlying human cognitive processes. Diffusion tensor imaging (DTI) and functional magnetic resonance imaging(fMRI) research has revealed that alterations of network characteristics were associated with cognitive impairments across attention, memory, executive function and language in LC. Currently, there is no accepted therapy for cognitive impairment in LC. Acupuncture, as a Traditional Chinese Medicine therapy, has potential to improve cognitive deficits for LC. However, research focusing on the impact of acupuncture on cognitive functions in LC is rare. Additionally, no one has evaluated the mechanism of acupuncture improving cognitive functions in LC.

Objective of the study:

This study aims to assess the effect of acupuncture treatment on cognitive function and explore the central mechanism of acupuncture therapy in improving cognitive function for LC using cognitive assessments, DTI and resting-state fMRI.

Study design:

A prospective, three-armed, randomized controlled trial with DTI and rs-fMRI. Adults with LC will be randomly assigned to acupuncture, sham acupuncture, or waitlist control group in a 1:1:1 ratio, receiving 8-week intervention or waiting. Cognitive function and topological attributes of brain networks will be examined at baseline and 8th week.

Study population:

Patients fulfilling World Health Organization (WHO) criteria for LC will be included in this study.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age 18-60 years * Fulfilling WHO criteria for long COVID * History of confirmed COVID-19 through RT-PCR of nasopharyngeal swab or antigen test of nasal swab ; * Having subjective cognitive problems * Native Chinese speakers * Right handedness * Voluntary to participate in the study and signing the informed consent form. Exclusion Criteria: * Preexisting cognitive symptoms before COVID-19 * Previous or current diagnosis of chronic conditions that may affect cognitive performances (such as neurological, psychiatric disorders, organ failure, chronic infectious diseases) * Prior loss of consciousness * History of major surgery within a year * Long-term use of drugs that may influence cognition(such as tranquilizer, antidepressant, immunosuppressor) * Previous acupuncture treatment within 3 months * Involvement of other clinical study within 4 weeks * Obesity(BMI≥28) * Sensory disorders(deafness, color blindness) * Limb dysfunction * Metal implantation * Claustrophobia * Pregnancy or lactation

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Chengdu University of Traditional Chinese Medicine Chengdu Sichuan
Chengdu University of Traditional Chinese Medicine Chengdu Sichuan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07355751 on ClinicalTrials.gov ↗ ← All trials in China